Department of Health and Human Services October 25, 2005 – Federal Register Recent Federal Regulation Documents

Advisory Committee on Childhood Lead Poisoning Prevention
Document Number: 05-21259
Type: Notice
Date: 2005-10-25
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Department of Health and Human Services, CDC published a document in the Federal Register of September 20, 2005, concerning the ACCLPP. Correction: In the Federal Register of September 20, 2005, (Volume 70, Number 1811) [Notices] Page 55132 ``Place: The Hubert Humphrey Federal Building, 200 Independence Avenue, Washington, DC 20021'' Should read: 330 Independence Avenue, Room 5051, Snow Room Cohen Building, Washington, DC 20201. Telephone: 202-619-0814. Contact Person For More Information: Claudine Johnson, Lead Poisoning Prevention Branch, Division of Emergency and Environmental Health Services, NCEH, CDC, 4770 Buford Hwy, NE., M/S F-40, Atlanta, Georgia 30341. Telephone: (770) 488-3300, fax: (770) 488-3635. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.
Availability of Draft Toxicological Profiles
Document Number: 05-21254
Type: Notice
Date: 2005-10-25
Agency: Agency for Toxic Substances and Disease Registry, Department of Health and Human Services
The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), Section 104(i)(3) [42 U.S.C. 9604(i)(3)] directs the Administrator of ATSDR to prepare toxicological profiles of priority hazardous substances and to revise and publish each updated toxicological profile as necessary. This notice announces the availability of the 19th set of toxicological profiles, which consists of one new draft and seven updated drafts, prepared by ATSDR for review and comment.
Office of the Assistant Secretary for Public Affairs; Statement of Organization, Functions and Delegations of Authority
Document Number: 05-21249
Type: Notice
Date: 2005-10-25
Agency: Office of the Secretary, Department of Health and Human Services
Advisory Committee on Infant Mortality; Notice of Meeting
Document Number: 05-21245
Type: Notice
Date: 2005-10-25
Agency: Department of Health and Human Services, Health Resources and Services Administration
Advisory Committee on Organ Transplantation; Notice of Meeting
Document Number: 05-21244
Type: Notice
Date: 2005-10-25
Agency: Department of Health and Human Services, Health Resources and Services Administration
The Health Resources and Services Administration published a notice in the Federal Register of September 29, 2005 (70 FR 56926- 56927) announcing an Advisory Committee on Organ Transplantation meeting on November 3-4 2005. The notice is being amended to change type of meeting, place, dates, and time.
National Advisory Council on Nurse Education and Practice; Notice of Meeting
Document Number: 05-21243
Type: Notice
Date: 2005-10-25
Agency: Department of Health and Human Services, Health Resources and Services Administration
Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science; Notice of Meeting
Document Number: 05-21241
Type: Notice
Date: 2005-10-25
Agency: Food and Drug Administration, Department of Health and Human Services
Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Food and Drug Administration Rapid Response Surveys
Document Number: 05-21240
Type: Notice
Date: 2005-10-25
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the use of rapid response surveys to obtain data on safety information to support quick- turnaround decisionmaking about potential safety problems or risk management solutions from health care professionals, hospitals and other user-facilities (e.g., nursing homes, etc.); consumers; manufacturers of biologics, drugs, and medical devices; distributors; and importers when FDA must quickly determine whether or not a problem with a biologic, drug, or medical device impacts the public health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.